HI
LGND icon

Harbour Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Harbour Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
+340
New +$80.1K ﹤0.01% 1962
2021
Q4 		– Sell
-48
Closed -$4K – 3226
2021
Q3 		$4K Hold
48
– – ﹤0.01% 3078
2021
Q2 		$4K Sell
48
-53
-52% -$4.41K ﹤0.01% 3145
2021
Q1 		$10K Buy
+101
New +$9.55K ﹤0.01% 2613

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbour Investments's LGND Position: Q2 2026 in Review

Harbour Investments opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 340 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #1962 among its holdings. This is a return to the name: Harbour Investments previously reported a position in LGND as recently as Q3 2021.

Harbour Investments first reported a position in LGND in Q1 2021 and has held it in 4 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Harbour Investments held 340 shares of Ligand Pharmaceuticals worth $107K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Harbour Investments position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1962 holding.
  • Harbour Investments first reported a position in Ligand Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.